Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report

5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Non-alcoholic fatty liver disease is one of the main causes of elevated liver enzymes and chronic liver disease worldwide. It ranges from steatosis to steatohepatitis, leading to cirrhosis and related liver dysfunction. Silymarin is a herbal medicine, mostly used for liver disorders owing to its supposed hepatoprotective action. This report recommends silymarin in a patient with diabetes and grade II non-alcoholic steatohepatitis, confirming significant hepatoprotective effects as shown by the reduction of liver enzyme activities.

Cite

CITATION STYLE

APA

Lee, Y. Y., & Tee, V. (2023). Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report. Drugs in Context, 12. https://doi.org/10.7573/dic.2023-2-10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free